Key Documents
NIH Biosketch available Online
Kiki Chang
- Associate Professor - Med Center Line, Psychiatry & Behavioral Science - Child Psychiatry
- Member, Bio-X
Contact Information
- Clinical Offices
Child & Adolescent Psychiatry Clinic 401 Quarry Rd MC 5719 Stanford, CA 94305 Telephone Work (650) 723-5511 Fax (650) 723-5531
- Academic Offices
Personal Information Email kchang88@stanford.edu Tel (650) 725-0956Not for medical emergencies or patient use
Clinical Focus
- Psychiatry, Child and Adolescent
- Child and Adolescent Psychiatry
Professional Education
- Board Certification: Child and Adolescent Psychiatry, American Board of Psychiatry and Neurology (2002)
- Board Certification: Psychiatry, American Board of Psychiatry and Neurology (2000)
- SUMC - Graduate Medical Education (1998) CA
- University of Cincinnati (1996) OH
- University of Cincinnati (1994) OH
- Tufts University (1993) MA
Web Site Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities.
- Consulting: Bristol-Myers Squibb, Lilly
Research Interests
As Director of the Pediatric Bipolar Disorders Program, Dr. Chang conducts research into various facets of bipolar disorder. He is currently conducting phenomenologic, biologic, pharmacologic, and genetic studies of bipolar disorder in adults and children. These studies include brain imaging (MRI, MRS, fMRI) and medication and therapy trials. He is particularly interested in detecting prodromal bipolar disorder in children who might then be treated to prevent the development of full bipolar disorder. To do this, he has been studying children of parents with bipolar disorder who are at high risk for developing the disorder themselves.
Publications
- J Am Acad Child Adolesc Psychiatry. 2009; (5): 519-32
- Psychiatry Res. 2009; (2): 113-20
- J Child Adolesc Psychopharmacol. 2009; (5): 547-51
- J Child Adolesc Psychopharmacol. 2009; (1): 51-9
- Dialogues Clin Neurosci. 2009; (1): 73-80
- Biol Psychiatry. 2009; (3): 238-44
- J Clin Psychiatry. 2008; 4-8
- Dev Psychopathol. 2008; (4): 1285-96
- J Clin Psychiatry. 2008; (3): e9
- Bipolar Disord. 2008; (3): 426-31
- Child Psychiatry Hum Dev. 2007; (3): 183-93
- Can J Psychiatry. 2007; (7): 418-25
- J Am Acad Child Adolesc Psychiatry. 2006; (3): 298-304
- Dev Psychopathol. 2006; (4): 1133-46
- J Child Adolesc Psychopharmacol. 2006; (3): 252-9
- Bipolar Disord. 2006; (4): 405-10
- Biol Psychiatry. 2006; (9): 1005-12
- Child Psychiatry Hum Dev. 2006; (1): 55-64
- Ann N Y Acad Sci. 2006; 235-47
- Bipolar Disord. 2005; (6): 497-506
- J Clin Psychiatry. 2005; (12): 1541-8
- J Child Adolesc Psychopharmacol. 2005; (6): 996-1004
- J Psychiatr Res. 2005; (6): 623-31
- Biol Psychiatry. 2005; (3): 197-203
- J Child Psychol Psychiatry. 2005; (1): 84-93
- Prim Care Companion J Clin Psychiatry. 2005; (1): 15-21
- Expert Rev Neurother. 2005; (2): 165-76
- J Am Acad Child Adolesc Psychiatry. 2005; (6): 565-73
- Bipolar Disord. 2005; (6): 589-97
- Expert Rev Neurother. 2004; (1): 69-77
- Arch Gen Psychiatry. 2004; (8): 781-92
- CNS Spectr. 2003; (4): 298-308
- Am J Med Genet C Semin Med Genet. 2003; (1): 26-35
- J Affect Disord. 2003; (1): 11-9
- J Clin Psychiatry. 2003; (8): 936-42
- Biol Psychiatry. 2003; (11): 1059-65
- Biol Psychiatry. 2003; (11): 945-51
- J Psychiatr Res. 2002 Sep-Oct; (5): 337-45
- Expert Opin Pharmacother. 2001; (4): 613-22
- Bipolar Disord. 2001; (2): 73-8
- J Child Adolesc Psychopharmacol. 2000; (1): 45-9
- J Am Acad Child Adolesc Psychiatry. 2000; (4): 453-60
- Biol Psychiatry. 1998; (10): 730-3